Dynamin-related protein 1 inhibition reduces hepatic PCSK9 secretion

Author:

Rogers Maximillian A1ORCID,Hutcheson Joshua D1ORCID,Okui Takehito1,Goettsch Claudia1ORCID,Singh Sasha A1ORCID,Halu Arda1ORCID,Schlotter Florian1ORCID,Higashi Hideyuki1,Wang Lixiang2ORCID,Whelan Mary C1,Mlynarchik Andrew K1,Daugherty Alan3ORCID,Nomura Masatoshi4ORCID,Aikawa Masanori15ORCID,Aikawa Elena156ORCID

Affiliation:

1. Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

2. Department of Medical Biochemistry, Kurume University School of Medicine, Kurume 830-0011, Japan

3. Saha Cardiovascular Research Center and Department of Physiology, University of Kentucky, Lexington, KY 40536, USA

4. Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan

5. Center for Excellence in Vascular Biology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

6. Department of Human Pathology, Sechenov First Moscow State Medical University, Moscow 119992, Russia

Abstract

Abstract Aims Proteostasis maintains protein homeostasis and participates in regulating critical cardiometabolic disease risk factors including proprotein convertase subtilisin/kexin type 9 (PCSK9). Endoplasmic reticulum (ER) remodeling through release and incorporation of trafficking vesicles mediates protein secretion and degradation. We hypothesized that ER remodeling that drives mitochondrial fission participates in cardiometabolic proteostasis. Methods and results We used in vitro and in vivo hepatocyte inhibition of a protein involved in mitochondrial fission, dynamin-related protein 1 (DRP1). Here, we show that DRP1 promotes remodeling of select ER microdomains by tethering vesicles at ER. A DRP1 inhibitor, mitochondrial division inhibitor 1 (mdivi-1) reduced ER localization of a DRP1 receptor, mitochondrial fission factor, suppressing ER remodeling-driven mitochondrial fission, autophagy, and increased mitochondrial calcium buffering and PCSK9 proteasomal degradation. DRP1 inhibition by CRISPR/Cas9 deletion or mdivi-1 alone or in combination with statin incubation in human hepatocytes and hepatocyte-specific Drp1-deficiency in mice reduced PCSK9 secretion (−78.5%). In HepG2 cells, mdivi-1 increased low-density lipoprotein receptor via c-Jun transcription and reduced PCSK9 mRNA levels via suppressed sterol regulatory binding protein-1c. Additionally, mdivi-1 reduced macrophage burden, oxidative stress, and advanced calcified atherosclerotic plaque in aortic roots of diabetic Apoe-deficient mice and inflammatory cytokine production in human macrophages. Conclusions We propose a novel tethering function of DRP1 beyond its established fission function, with DRP1-mediated ER remodeling likely contributing to ER constriction of mitochondria that drives mitochondrial fission. We report that DRP1-driven remodeling of select ER micro-domains may critically regulate hepatic proteostasis and identify mdivi-1 as a novel small molecule PCSK9 inhibitor.

Funder

National Institutes of Health

Japanese Society for the Promotion of Science

Japan Medical Association

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Reference46 articles.

1. Proteostasis in cardiac health and disease;Henning;Nat Rev Cardiol,2017

2. SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion;Chen;Elife,2013

3. Remodeling of ER-exit sites initiates a membrane supply pathway for autophagosome biogenesis;Ge;EMBO Rep,2017

4. ER-phagy: quality control and turnover of endoplasmic reticulum;Chino;Trends Cell Biol,2020

5. GRP94 regulates circulating cholesterol levels through blockade of PCSK9-induced LDLR degradation;Poirier;Cell Rep,2015

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3